Atlas Trials

Prevention of CMV Infection or Disease

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Prevention of CMV Infection or Disease

RecordFirmDate
Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001) (NCT02137772)Merck Sharp & Dohme LLC2014-06-06

Track Prevention of CMV Infection or Disease automatically

Every clearance here is in the API, with alerts when new ones post.